Allergan stock climbs amid $46-billion bid

Bill Ackman and Valeant make offer for the maker of Botox.Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight.